Loading...

PMCB PHARMACYTE BIOTECH INC Management Changes 8-K Filing

PHRM

PMCB

PHARMACYTE BIOTECH INC

(PMCB)

2023 8-K

Summary

Summary

Investment Agreement

Stock Offering Details

Accountant Change

Acquisition Agreement

Annual Meeting Voting Results

Grants to Interim CEO and CFO

Entry into Material Definit...

Accountant Change

Resignation of Auditor

Reorganizations

Private Placement

Share Repurchase Program

External Links:

PharmaCyte Biotech approved one-time grants to its Interim CEO and CFO, including cash and stock options.

AI Assistant

PHARMACYTE BIOTECH INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.